Neutralizing Anti-SARS-CoV-2 Antibody Titer and Reported Adverse Effects, in a Sample of Italian Nursing Home Personnel after Two Doses of the BNT162b2 Vaccine Administered Four Weeks Apart.
Neutralizing Anti-SARS-CoV-2 Antibody Titer and Reported Adverse Effects, in a Sample of Italian Nursing Home Personnel after Two Doses of the BNT162b2 Vaccine Administered Four Weeks Apart.
复制标题
DOI:
10.3390/vaccines9060652
复制
发表时间:
2021-06-15
期刊:
影响因子:
7.8
通讯作者:
Gobba F
中科院分区:
文献类型:
--
作者:
Modenese A;Paduano S;Bargellini A;Bellucci R;Marchetti S;Bruno F;Grazioli P;Vivoli R;Gobba F
Background: The immunization of healthcare workers (HCWs) plays a recognized key role in prevention in the COVID-19 pandemic: in Italy, the vaccination campaign began at the end of December 2020. A better knowledge of the on-field immune response in HCWs, of adverse effects and of the main factors involved is fundamental. Methods: We performed a study on workers at a nursing home in Northern Italy, vaccinated in January–February 2021 with two doses of the BNT162b2 vaccine four weeks apart, instead of the three weeks provided for in the original manufacturer protocol. One month after the second dose, the serological titer of IgG-neutralizing anti-RBD antibodies of the subunit S1 of the spike protein of SARS-CoV-2 was determined. The socio-demographic and clinical characteristics of the subjects and adverse effects of vaccination were collected by questionnaire. Results: In all of the workers, high antibody titer, ranging between 20 and 760 times the minimum protective level were observed. Titers were significantly higher in subjects with a previous COVID-19 diagnosis. Adverse effects after the vaccine were more frequent after the second dose, but no severe adverse effects were observed. Conclusions: The two doses of the BNT162b2 vaccine, even if administered four weeks apart, induced high titers of anti-SARS-CoV-2 neutralizing IgG in all the operators included in the study.
登录
查看更多内容
影响因子:
7.3
作者:
Colucci M;Piano Mortari E;Zotta F;Corrente F;Concato C;Carsetti R;Emma F;Vivarelli M
通讯作者:
Vivarelli M
DOI:
10.1016/j.cca.2021.04.006
发表时间:
2021-08
期刊:
Clinica chimica acta; international journal of clinical chemistry
影响因子:
--
作者:
Padoan A;Dall'Olmo L;Rocca FD;Barbaro F;Cosma C;Basso D;Cattelan A;Cianci V;Plebani M
通讯作者:
Plebani M
DOI:
10.1002/dmrr.3465
发表时间:
2022-01
期刊:
Diabetes/metabolism research and reviews
影响因子:
--
作者:
Watanabe M;Balena A;Tuccinardi D;Tozzi R;Risi R;Masi D;Caputi A;Rossetti R;Spoltore ME;Filippi V;Gangitano E;Manfrini S;Mariani S;Lubrano C;Lenzi A;Mastroianni C;Gnessi L
通讯作者:
Gnessi L
DOI:
10.26355/eurrev_202102_24877
发表时间:
2021-01-01
影响因子:
3.3
作者:
Meo, S. A.;Bukhari, I. A.;Klonoff, D. C.
通讯作者:
Klonoff, D. C.
DOI:
10.1016/s2666-5247(21)00088-4
发表时间:
2021-05
期刊:
The Lancet. Microbe
影响因子:
--
作者:
通讯作者:
--